Bundesverband der Pharmazeutischen Industrie e.V.

BPI Germany is a strong alliance of pharmaceutical companies, representing the industry across the entire value chain in Germany and Europe with over 70 years of experience in drug research, development, authorization, manufacturing, and marketing. It encompasses around 260 member companies, from multinationals to SMEs, Mid-Caps, and Start-ups, ensuring drug supply for patients across the EU and globally. BPI operates from Berlin and Brussels, with regional associations representing interests at the federal state level. Members benefit from services, including analyses, fast information, and over 50 working groups addressing current topics. BPI influences social and legal frameworks at all governmental levels.